Ecolab Inc. ECL · NYSE
$305.81 -2.92% (-$9.20)
Summary
67 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 24% a year over the last 3 years.
- Out of every 100 USD of revenue, 12 USD is left as net profit.
- It has raised its dividend 21 years in a row and pays out only 39% of profit.
- It earns 9.2 USD a year on every 100 USD of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 41.2 USD for 1 USD of yearly profit. Over the last five years it was 41.5 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 6.4% a year over 5 years. Over the last 3 years it grew by 4.3% a year. For the next fiscal year analysts expect revenue to grow by 11%. Earnings per share grew by 24% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 56 USD
- Sales and administration 27 USD
- Taxes and other 5.1 USD
- Net profit 12 USD
Net profit, industry median (Chemicals - Specialty) 6.0 USD
Out of every 100 USD of revenue, 12 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.95%
- Paid out of profit
- 39%
- Raised in a row
- 21 years
You receive $2.92 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 29
- Hold 7
- Sell 1
Today's price within the analysts' price targets
The average target of $328 is 7.3% above today's price. 78% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Global Water 50%
- Global Institutional and Specialty 38%
- Global Pest Elimination 7.8%
- Global Life Sciences 4.7%
By region
- UNITED STATES 53%
- Europe 20%
- Asia Pacific 8.5%
- Latin America 6.8%
- C [N] 4.5%
- Other 7.1%
Global Water brings in 50% of revenue. Global Institutional and Specialty grew fastest, by 11% a year.
Segments in detail